Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Antiretroviral Therapy
100%
HIV Infection
100%
Interleukin-2
100%
Aldesleukin
100%
Extended Follow-up
100%
Adverse Events
58%
Opportunistic Diseases
25%
CD4+
16%
Hazard Ratio
16%
Clinical Trials
8%
ESPRIT
8%
Clinical Events
8%
Viral Load
8%
Load Response
8%
Clinical Benefit
8%
Cox Proportional Hazards Model
8%
First Grade
8%
Cell Count
8%
CD4 Cells
8%
Peri
8%
Death Events
8%
Event Outcomes
8%
IL-2 Therapy
8%
Delayed Initiation
8%
Cell Load
8%
HIV-infected Patients
8%
Untreated Controls
8%
Disease Events
8%
Medicine and Dentistry
Human Immunodeficiency Virus Infection
100%
Antiretroviral Therapy
100%
Aldesleukin
100%
Interleukin 2
100%
Adverse Event
53%
Diseases
23%
Arm
15%
Hazard Ratio
15%
Clinical Trial
7%
Human Immunodeficiency Virus
7%
Proportional Hazards Model
7%
Cell Count
7%
Pharmacology, Toxicology and Pharmaceutical Science
Aldesleukin
100%
Human Immunodeficiency Virus Infection
100%
Interleukin 2
100%
Adverse Event
53%
Diseases
23%
Clinical Trial
7%
HIV
7%
Psychology
Hazard Ratio
100%
Infectious Disease
100%
Clinical Trial
50%
Proportional Hazards Regression Model
50%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus
100%
Interleukin 2
100%
CD4
15%
Clinical Trial
7%
Virus Load
7%
CD4 Lymphocyte Count
7%
Agricultural and Biological Sciences
Human Immunodeficiency Virus
100%
Interleukin 2
100%
CD4
23%
Clinical Trial
7%